Accuvest Global Advisors Amgen Inc Transaction History

Accuvest Global Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 23, 2020	SELL	$182.24 - $241.7 $9,840 - $13,051	-54 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$189.21 - $243.2 $10,217 - $13,132	54 New	54 $13,000
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $286,062 - $342,762	-1,643 Closed	0 $0
Q2 2019 Jul 17, 2019	BUY	$166.7 - $195.41 $273,888 - $321,058	1,643 New	1,643 $303,000
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $337,532 - $394,009	-1,892 Closed	0 $0
Q3 2018 Oct 31, 2018	BUY	$185.29 - $208.89 $350,568 - $395,219	1,892 New	1,892 $392,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Accuvest Global Advisors, based on Form 13F filings with the SEC.

Stay updated on Accuvest Global Advisors with notifications on news.